Peripheral γδ T Cells Regulate Neutrophil Expansion and Recruitment in Experimental Psoriatic Arthritis.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
09 2022
Historique:
revised: 01 03 2022
received: 09 12 2021
accepted: 17 03 2022
pubmed: 24 3 2022
medline: 3 9 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

This study was undertaken to identify the mechanistic role of γδ T cells in the pathogenesis of experimental psoriatic arthritis (PsA). In this study, we performed interleukin-23 (IL-23) gene transfer in wild-type (WT) and T cell receptor δ-deficient (TCRδ We demonstrated that γδ T cells support systemic granulopoiesis, which is critical for murine PsA-like pathology. Briefly, γδ T cell ablation inhibited the expression of neutrophil chemokines CXCL1 and CXCL2 and neutrophil CD11b+Ly6G+ accumulation in the aforementioned PsA-related tissues. Although significantly reduced expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-17A was detected systemically in TCRδ Our findings do not support the notion that tissue-resident γδ T cells initiate the disease but demonstrate a novel role of γδ T cells in neutrophil regulation that can be exploited therapeutically in PsA patients.

Identifiants

pubmed: 35320625
doi: 10.1002/art.42124
pmc: PMC9427669
mid: NIHMS1790960
doi:

Substances chimiques

Interleukin-17 0
Receptors, Antigen, T-Cell, gamma-delta 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1524-1534

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR062173
Pays : United States

Informations de copyright

© 2022 American College of Rheumatology.

Références

J Immunol. 2001 Aug 1;167(3):1601-8
pubmed: 11466382
Arthritis Rheum. 2010 Feb;62(2):402-13
pubmed: 20112358
J Immunol. 2007 Oct 15;179(8):5576-83
pubmed: 17911645
J Clin Invest. 2018 Mar 1;128(3):1026-1042
pubmed: 29400698
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):E3562-70
pubmed: 25114209
J Exp Med. 1993 Sep 1;178(3):971-84
pubmed: 8350063
J Exp Med. 2020 May 4;217(5):
pubmed: 32097462
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
Cell. 1993 Feb 12;72(3):337-48
pubmed: 8381716
J Immunol. 2016 Dec 1;197(11):4403-4412
pubmed: 27798153
Front Immunol. 2019 Mar 18;10:473
pubmed: 30936874
J Clin Invest. 2020 Apr 1;130(4):1863-1878
pubmed: 32149730
Arthritis Rheum. 2009 Aug;60(8):2294-303
pubmed: 19644886
Nat Rev Rheumatol. 2015 Mar;11(3):189-94
pubmed: 25422000
J Pathol. 2006 Jan;208(1):35-43
pubmed: 16278818
Arthritis Res Ther. 2010;12(1):R29
pubmed: 20167120
N Engl J Med. 2009 Jul 30;361(5):496-509
pubmed: 19641206
Immunity. 2011 Oct 28;35(4):596-610
pubmed: 21982596
Immunity. 2018 Feb 20;48(2):350-363.e7
pubmed: 29426701
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Ann Rheum Dis. 2011 Sep;70(9):1641-4
pubmed: 21623003
Nat Commun. 2017 Nov 15;8(1):1510
pubmed: 29142230
Nat Med. 2012 Jul 01;18(7):1069-76
pubmed: 22772566
J Exp Med. 2006 Nov 27;203(12):2577-87
pubmed: 17074928
Semin Immunopathol. 2019 Sep;41(5):595-605
pubmed: 31506867
J Immunol. 2007 Dec 15;179(12):8274-9
pubmed: 18056371
J Clin Invest. 2012 Jun;122(6):2252-6
pubmed: 22546855
J Invest Dermatol. 2000 May;114(5):976-83
pubmed: 10771480
J Immunol. 2011 Jul 15;187(2):951-9
pubmed: 21670317
Immunity. 2009 Aug 21;31(2):331-41
pubmed: 19682929
J Dermatol. 2016 Mar;43(3):305-10
pubmed: 26381893
Nat Immunol. 2006 Sep;7(9):937-45
pubmed: 16906166
Am J Dermatopathol. 2015 Jun;37(6):429-39
pubmed: 25993403
J Clin Invest. 2017 Nov 1;127(11):4031-4041
pubmed: 28945199
Eur J Immunol. 2009 Feb;39(2):372-9
pubmed: 19130484
Immunity. 2005 Mar;22(3):285-94
pubmed: 15780986
PLoS One. 2021 May 13;16(5):e0247149
pubmed: 33983951
Nat Commun. 2015 Jun 25;6:7464
pubmed: 26108163
Nat Rev Rheumatol. 2017 Nov 21;13(12):731-741
pubmed: 29158573
N Engl J Med. 2017 Mar 9;376(10):957-970
pubmed: 28273019
Nat Commun. 2019 Jan 2;10(1):9
pubmed: 30602780
J Immunol. 2012 Jun 15;188(12):6287-99
pubmed: 22566565
Ann Rheum Dis. 2014 Feb;73(2):437-45
pubmed: 23921997
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
Sci Rep. 2018 May 15;8(1):7590
pubmed: 29765156
J Cutan Pathol. 2018 Nov;45(11):824-830
pubmed: 30073694
J Biol Chem. 2001 Jan 5;276(1):563-8
pubmed: 11032840
Arthritis Rheum. 2000 Apr;43(4):844-51
pubmed: 10765929
Arthritis Rheum. 2008 Dec;58(12):3705-9
pubmed: 19035472
Nat Commun. 2017 Jun 05;8:15632
pubmed: 28580944

Auteurs

Cuong Thach Nguyen (CT)

University of California, Davis.

Hiroki Furuya (H)

Harvard Medical School, Boston, Massachusetts.

Dayasagar Das (D)

University of California, Davis.

Alina I Marusina (AI)

University of California, Davis.

Alexander A Merleev (AA)

University of California, Davis.

Resmi Ravindran (R)

University of California, Davis.

Zahra Jalali (Z)

Harvard Medical School, Boston, Massachusetts.

Imran H Khan (IH)

University of California, Davis.

Emanual Maverakis (E)

University of California, Davis.

Iannis E Adamopoulos (IE)

University of California, Davis, and Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH